Samrat Pharmachem share price
You have to be logged in to add this to Watchlist.- ₹257.00(1.86%)December 5, 2025 15:28:36 PM IST
- NSE
- BSE
- Vol : 0.43 K (NSE + BSE)Last 20 day avg : 1.44 K
Samrat Pharmachem is trading 1.86% upper at Rs 257.00 as compared to its last closing price. Samrat Pharmachem has been trading in the price range of 258.95 & 250.00. Samrat Pharmachem has given -34.07% in this year & -1.18% in the last 5 days. Samrat Pharmachem has TTM P/E ratio 57.41 as compared to the sector P/E of 19.17.The company posted a net profit of -0.59 Crores in its last quarter.Listed peers of Samrat Pharmachem include Torrent Pharmaceuticals (-0.74%), Sun Pharmaceutical Industries (-0.75%), Cipla (-0.04%).The Mutual Fund holding in Samrat Pharmachem was at -% in . The MF holding has - from the last quarter. The FII holding in Samrat Pharmachem was at 3.24% in 30 Jun 2022. The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 06, 2025, 01:14 PM UTC
- BetaLow volatility-0.09Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.14The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.40Annual dividends as a percentage of the stock price.
- P/BLower than historical values1.09The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values49.69Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-1.95The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 3,773.70 | -0.74 | 1,27,661.97 | 66.64 | 16.92 | 0.84 | 17.62 |
| Sun Pharmaceutical Industries | Bullish | 1,805.00 | -0.75 | 4,33,140.85 | 37.94 | 6.04 | 0.88 | 0.50 |
| Cipla | Neutral | 1,520.55 | -0.04 | 1,22,825.65 | 23.33 | 3.94 | 0.85 | - |
| Dr Reddy's Laboratories | Bullish | 1,276.55 | -0.04 | 1,06,330.42 | 18.80 | 3.17 | 0.63 | 2.34 |
| Divi's Laboratories | Bullish | 6,468.25 | -0.04 | 1,73,113.62 | 78.27 | 11.47 | 0.46 | - |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE103E01016
- BSE Code530125
- NSE Code
Samrat Pharmachem is trading at 257.00 as on Fri Dec 05 2025 09:58:36. This is 1.86% upper as compared to its previous closing price of 252.30.
The market capitalization of Samrat Pharmachem is 79.50 Cr as on Fri Dec 05 2025 09:58:36.
The 52 wk high for Samrat Pharmachem is 449.45 whereas the 52 wk low is 245.00
Samrat Pharmachem can be analyzed on the following key metrics -
- TTM P/E: 57.41
- Sector P/E: 19.17
- Dividend Yield: 0.40%
- D/E ratio: 0.15
Samrat Pharmachem reported a net profit of 7.11 Cr in 2025.
EQUITY QUICK LINKS
Samrat Pharmachem QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.